Ruxolitinib
Product Description
ZHEJIANG HISUN PHARMACEUTICAL CO., LTD.
-
Country/Region:China
-
On CPHI since:2015
-
Certificates:4
-
Employees:5000+
Company types
Primary activities
Categories
ZHEJIANG HISUN PHARMACEUTICAL CO., LTD.
-
Country/Region:China
-
On CPHI since:2015
-
Certificates:4
-
Employees:5000+
Company types
Primary activities
More Products from ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. (99)
-
Product Pretomanid
Therapeutic Area: Drug-resistant Tuberculosis
Status: Early
-
Product Relebactam
Therapeutic Area: Infection
Status: Early
-
Product Resmetirom
Therapeutic Area: NASH
Status: Early
-
Product Rezafungin
Therapeutic Area: Infection
Status: Early
-
Product Rifamycin O
IntermediateUS DMF -
Product Rimegepant
Therapeutic Area: Migraine
Status: Early
-
Product S-Methoprene
API for Animal HealthMARA
CN Status
-
Product Sarecycline
Therapeutic Area: Acne VulgarisStatus: Pilot -
Product Selamectin
API for Animal HealthEP, MARA
CN Status -
Product Sirolimus
Immunology APIIn house
USDMF(Submitted), EDMF, CN Status(A) -
Product Tacrolimus
Immunology APIUSP, EP, IP
USDMF(Submitted), CEP, CN Status(A) -
Product Teicoplanin
Anti-infection APIEP, ChP+YBH, YBY
CN Status(A)